Largest pharmaceutical companies in the United States by total debt
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
AbbVie leads the 24 pharmaceutical companies in the United States ranked by total debt, at SEK 689.4B, ahead of Pfizer (SEK 661.8B) and Merck & Co (SEK 503.5B). Figures as of 20 Nov 2026, 16:17 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- AbbVieSEK 689.4B
- Median
- SEK 23.4B
- Combined market value
- SEK 38.46T
- Countries
- 1
- Not ranked
- 20no total debt on file
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total debt ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | SEK 689.4B | SEK 5.19T | SEK 2,937.16 | 1.42% up | 20% up | ||
| 2 | PfizerPFE · Health Care | SEK 661.8B | SEK 1.61T | SEK 282.82 | 0.55% up | 10% up | ||
| 3 | Merck & CoMRK · Health Care | SEK 503.5B | SEK 3.41T | SEK 1,384.47 | 2.06% up | 36% up | ||
| 4 | Johnson & JohnsonJNJ · Health Care | SEK 489.6B | SEK 6.66T | SEK 2,765.97 | 1.37% up | 31% up | ||
| 5 | Bristol-Myers SquibbBMY · Health Care | SEK 460.8B | SEK 1.24T | SEK 605.67 | 1.65% up | 26% up | ||
| 6 | Eli LillyLLY · Health Care | SEK 434.1B | SEK 12.33T | SEK 13,837.18 | 0.27% up | 28% up | ||
| 7 | ViatrisVTRS · Health Care | SEK 147.2B | SEK 229.5B | SEK 200.19 | 1.41% down | 90% up | ||
| 8 | Abbott LaboratoriesABT · Health Care | SEK 132.1B | SEK 1.84T | SEK 1,064.88 | 0.38% up | 19% down | ||
| 9 | ZoetisZTS · Health Care | SEK 92.4B | SEK 336.4B | SEK 827.82 | 0.32% up | 34% down | ||
| 10 | Royalty PharmaRPRX · Health Care | SEK 91.4B | SEK 401.5B | SEK 698.31 | 0.96% up | 74% up | ||
| 11 | Elanco Animal HealthELAN · Health Care | SEK 41B | SEK 132.9B | SEK 265.97 | 0.95% down | 18% up | ||
| 12 | Amneal PharmaceuticalsAMRX · Health Care | SEK 26.3B | SEK 75.5B | SEK 216.63 | 0.84% down | 79% up | ||
| 13 | BridgeBio PharmaBBIO · Health Care | SEK 20.5B | SEK 154B | SEK 790.49 | 1.00% down | 15% up | ||
| 14 | Regeneron PharmaceuticalsREGN · Health Care | SEK 20.3B | SEK 985.2B | SEK 9,524.03 | 1.09% up | 22% up | ||
| 15 | Ionis PharmaceuticalsIONS · Health Care | SEK 18.5B | SEK 46.7B | SEK 280.57 | 0.92% up | 64% down | ||
| 16 | InsmedINSM · Health Care | SEK 5.6B | SEK 328B | SEK 1,495.03 | 1.33% up | 27% down | ||
| 17 | Madrigal PharmaceuticalsMDGL · Health Care | SEK 3.5B | SEK 92.9B | SEK 3,998.05 | 1.34% down | 28% down | ||
| 18 | Legend BiotechLEGN · Health Care | SEK 3.3B | SEK 31.2B | SEK 160.76 | 2.24% down | 43% down | ||
| 19 | CytokineticsCYTK · Health Care | SEK 2.9B | SEK 74.3B | SEK 533.72 | 1.54% up | 21% down | ||
| 20 | TG TherapeuticsTGTX · Health Care | SEK 2.5B | SEK 99.9B | SEK 660.83 | 0.28% down | 103% up | ||
| 21 | Cogent BiosciencesCOGT · Health Care | SEK 2.3B | SEK 48.4B | SEK 278.12 | 1.84% down | 25% down | ||
| 22 | Axsome TherapeuticsAXSM · Health Care | SEK 1.9B | SEK 70.8B | SEK 1,346.78 | 2.82% down | 9% down | ||
| 23 | Rhythm PharmaceuticalsRYTM · Health Care | SEK 1.1B | SEK 80.8B | SEK 1,164.98 | 2.35% down | 15% up | ||
| 24 | Definium TherapeuticsDFTX · Health Care | SEK 414.5M | SEK 40.9B | SEK 298.44 | 0.88% down | 176% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 10.2137 SEK). 20 companies have no total debt on file and are not ranked here.
Questions and answers
Which pharmaceutical companies in the United States rank first by total debt?
AbbVie (SEK 689.4B), Pfizer (SEK 661.8B) and Merck & Co (SEK 503.5B) are the top three of the 24 pharmaceutical companies in the United States ranked by total debt as of 20 Nov 2026, 16:17 UTC.
How many pharmaceutical companies in the United States are in this ranking?
24 are ranked by total debt. 20 more have no total debt on file and are left out rather than ranked at zero.
What are these pharmaceutical companies in the United States worth together?
The 24 pharmaceutical companies in the United States ranked by total debt have a combined market value of SEK 38.46T as of 20 Nov 2026, 16:17 UTC.
What does ranking by total debt measure?
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by total debt”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=total-debt
Underlying data: Yahoo Finance; SEC EDGAR.